Non-small-cell lung cancers: a heterogeneous set of diseases, Nature Reviews Cancer, vol.8, issue.8, pp.535-581, 2014. ,
DOI : 10.1038/nrc3775
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-86, 2015. ,
DOI : 10.1002/ijc.29210
NCCN guidelines insights: Non-small cell lung cancer, version 4.2016, J Natl Compr Canc Netw, vol.14, pp.255-64, 2016. ,
Thrombin signalling and protease-activated receptors, Nature, vol.407, issue.6801, pp.258-64, 2000. ,
DOI : 10.1038/35025229
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation, Cell, vol.64, issue.6, pp.1057-68, 1991. ,
DOI : 10.1016/0092-8674(91)90261-V
PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells, Cell, vol.120, issue.3, pp.303-316, 2005. ,
DOI : 10.1016/j.cell.2004.12.018
Differential expression ofProtease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples, International Journal of Cancer, vol.160, issue.3, pp.372-380, 2005. ,
DOI : 10.1002/ijc.20607
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma, Human Pathology, vol.36, issue.6, pp.676-85, 2005. ,
DOI : 10.1016/j.humpath.2005.04.008
Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer, The Prostate, vol.59, issue.7, pp.743-56, 2007. ,
DOI : 10.1002/pros.20503
Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer, The American Journal of Pathology, vol.179, issue.1, pp.513-536, 2011. ,
DOI : 10.1016/j.ajpath.2011.03.025
Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP- 1) in gastric cancer, Anticancer Res, vol.28, pp.847-54, 2008. ,
Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA, Cancer Research, vol.68, issue.21, pp.9078-86, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-2397
PAR-1 and Thrombin: The Ties That Bind the Microenvironment to Melanoma Metastasis, Cancer Research, vol.71, issue.21, pp.6561-6567, 2011. ,
DOI : 10.1158/0008-5472.CAN-11-1432
Management of non-small-cell lung cancer: recent developments, The Lancet, vol.382, issue.9893, pp.709-728, 2013. ,
DOI : 10.1016/S0140-6736(13)61502-0
Tumor???stromal interactions in lung cancer: novel candidate targets for therapeutic intervention, Expert Opinion on Investigational Drugs, vol.9, issue.8, pp.1107-1129, 2012. ,
DOI : 10.1158/1078-0432.CCR-10-2805
Microenvironmental regulation of tumor progression and metastasis, Nature Medicine, vol.87, issue.11, pp.1423-1460, 2013. ,
DOI : 10.1016/j.ccr.2013.02.013
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen, Cancer Research, vol.75, issue.19, pp.4235-4278, 2015. ,
DOI : 10.1158/0008-5472.CAN-15-0964
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809049
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance, International Journal of Cancer, vol.11, issue.Suppl 1, pp.2294-304, 2014. ,
DOI : 10.1002/ijc.28726
Injury-Related Factors and Conditions Down-Regulate the Thrombin Receptor (PAR-1) in a Human Neuronal Cell Line, Journal of Neurochemistry, vol.71, issue.3, pp.1034-50, 1998. ,
DOI : 10.1046/j.1471-4159.1998.71031034.x
Thrombin Responses in Human Endothelial Cells. CONTRIBUTIONS FROM RECEPTORS OTHER THAN PAR1 INCLUDE THE TRANSACTIVATION OF PAR2 BY THROMBIN-CLEAVED PAR1, Journal of Biological Chemistry, vol.275, issue.18, pp.13502-13511, 2000. ,
DOI : 10.1074/jbc.275.18.13502
CD163, American Journal of Clinical Pathology, vol.122, issue.5, pp.794-801, 2004. ,
DOI : 10.1309/QHD6YFN81KQXUUH6
Myofibroblasts and mechano-regulation of connective tissue remodelling, Nature Reviews Molecular Cell Biology, vol.3, issue.5, pp.349-63, 2002. ,
DOI : 10.1038/nrm809
Differential expression of protease-activated receptors-1 and ?2 in stromal fibroblasts of normal, benign, and malignant human tissues, Am J Pathol, vol.158, pp.2031-2072, 2001. ,
Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis, The Prostate, vol.166, issue.7, pp.727-763, 2009. ,
DOI : 10.1002/pros.20920
Kallikrein-related peptidase-4 initiates tumor??????stroma interactions in prostate cancer through protease-activated receptor-1, International Journal of Cancer, vol.121, issue.3, pp.599-610, 2010. ,
DOI : 10.1002/ijc.24904
Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas, Cancer, vol.28, issue.3, pp.703-716, 2003. ,
DOI : 10.1002/cncr.11087
Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis, Oncotarget, vol.6, pp.35304-35318, 2015. ,
Absence of Proteinase-Activated Receptor-1 Signaling Affords Protection from Bleomycin-Induced Lung Inflammation and Fibrosis, The American Journal of Pathology, vol.166, issue.5, pp.1353-65, 2005. ,
DOI : 10.1016/S0002-9440(10)62354-1
Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis, Thorax, vol.25, issue.2, pp.152-60, 2014. ,
DOI : 10.1136/thoraxjnl-2013-203877
Targeting A549 lung adenocarcinoma cell growth and invasion with protease???activated receptor???1 siRNA, Molecular Medicine Reports, vol.9, pp.1787-93, 2014. ,
DOI : 10.3892/mmr.2014.2023
Targeting the Tumor Stroma as a Novel Treatment Strategy for Breast Cancer, Adv Pharmacol, vol.65, pp.45-61, 2012. ,
DOI : 10.1016/B978-0-12-397927-8.00003-8
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer, Science, vol.324, issue.5933, pp.1457-61, 2009. ,
DOI : 10.1126/science.1171362
A Tumor-stroma Targeted Oncolytic Adenovirus Replicated in Human Ovary Cancer Samples and Inhibited Growth of Disseminated Solid Tumors in Mice, Molecular Therapy, vol.20, issue.12, pp.2222-2255, 2012. ,
DOI : 10.1038/mt.2012.147
Clinical significance of serum protease activated receptor1 levels in patients with lung cancer, Eur Rev Med Pharmacol Sci, vol.20, pp.243-252, 2016. ,
Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non-Small-Cell Lung Cancer, Clinical Lung Cancer, vol.7, issue.6, pp.395-400, 2006. ,
DOI : 10.3816/CLC.2006.n.023
Increased expression of tissue factor and protease-activated receptor-1 does not correlate with thrombosis in human lung adenocarcinoma, Brazilian Journal of Medical and Biological Research, vol.43, issue.4, pp.403-411, 2010. ,
DOI : 10.1590/S0100-879X2010007500017